Inhibition of

Arenaviridae Lassa virus Lymphocytic choriomeningitis virus Mopeia virus alendronate compound optimization exonucleases metal chelation

Journal

IUCrJ
ISSN: 2052-2525
Titre abrégé: IUCrJ
Pays: England
ID NLM: 101623101

Informations de publication

Date de publication:
01 Jul 2022
Historique:
received: 07 03 2022
accepted: 11 05 2022
entrez: 18 7 2022
pubmed: 19 7 2022
medline: 19 7 2022
Statut: epublish

Résumé

Arenaviruses are emerging enveloped negative-sense RNA viruses that cause neurological and hemorrhagic diseases in humans. Currently, no FDA-approved vaccine or therapeutic agent is available except for ribavirin, which must be administered early during infection for optimum efficacy. A hallmark of arenavirus infection is rapid and efficient immune suppression mediated by the exonuclease domain encoded by the nucleoprotein. This exonuclease is therefore an attractive target for the design of novel antiviral drugs since exonuclease inhibitors might not only have a direct effect on the enzyme but could also boost viral clearance through stimulation of the innate immune system of the host cell. Here,

Identifiants

pubmed: 35844481
doi: 10.1107/S2052252522005061
pii: S2052252522005061
pmc: PMC9252148
doi:

Types de publication

Journal Article

Langues

eng

Pagination

468-479

Informations de copyright

© Thi Hong Van Nguyen et al. 2022.

Références

Viruses. 2012 Oct 09;4(10):2031-48
pubmed: 23202452
J Biol Chem. 2011 Jul 15;286(28):25246-55
pubmed: 21566148
PLoS Pathog. 2009 May;5(5):e1000455
pubmed: 19478873
J Virol. 2010 Sep;84(18):9096-104
pubmed: 20592097
PLoS One. 2014 Aug 08;9(8):e100711
pubmed: 25105746
Nucleic Acids Res. 2015 Jul 1;43(W1):W448-54
pubmed: 25855812
mBio. 2022 Jan 25;:e0322621
pubmed: 35073739
Mini Rev Med Chem. 2004 Sep;4(7):711-9
pubmed: 15379639
Biochim Biophys Acta. 1982 Feb 26;696(2):115-23
pubmed: 6277381
Acta Crystallogr D Struct Biol. 2019 Oct 1;75(Pt 10):861-877
pubmed: 31588918
PLoS Pathog. 2010 Sep 16;6(9):e1001038
pubmed: 20862324
Proteins. 2010 Jun;78(8):1950-8
pubmed: 20408171
Protein Sci. 2018 Jan;27(1):293-315
pubmed: 29067766
Leuk Res. 2001 Jan;25(1):77-83
pubmed: 11137564
Nucleic Acids Res. 2009 Apr;37(7):2411-7
pubmed: 19321497
Antiviral Res. 2019 Feb;162:79-89
pubmed: 30557576
J Virol. 2016 Mar 28;90(8):3810-3818
pubmed: 26865707
Proc Natl Acad Sci U S A. 2011 Nov 29;108(48):19365-70
pubmed: 22084115
Acta Crystallogr D Biol Crystallogr. 2006 Jan;62(Pt 1):72-82
pubmed: 16369096
J Virol. 2015 Jul;89(13):6595-607
pubmed: 25878103
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
Front Microbiol. 2017 Mar 20;8:440
pubmed: 28373864
ChemMedChem. 2006 Feb;1(2):267-73
pubmed: 16892359
BMC Cancer. 2006 Mar 15;6:60
pubmed: 16539721
Cancer Res. 2002 May 1;62(9):2708-14
pubmed: 11980672
Biochemistry. 2015 Dec 8;54(48):7142-55
pubmed: 26598179
Proc Natl Acad Sci U S A. 1993 Jul 15;90(14):6498-502
pubmed: 8341661
J Biol Chem. 2007 Feb 2;282(5):3337-46
pubmed: 17145704
Acta Crystallogr D Struct Biol. 2017 Aug 01;73(Pt 8):641-649
pubmed: 28777079
Ann N Y Acad Sci. 2006 Apr;1068:367-401
pubmed: 16831938
Proc Natl Acad Sci U S A. 2011 Feb 8;108(6):2396-401
pubmed: 21262835
Antimicrob Agents Chemother. 2011 Feb;55(2):782-7
pubmed: 21115797
Virus Res. 2017 Apr 15;234:118-134
pubmed: 28137457
J Comput Chem. 2010 Jan 30;31(2):455-61
pubmed: 19499576
Bone. 2011 Jul;49(1):34-41
pubmed: 21111853
BMC Cancer. 2007 Jan 12;7:8
pubmed: 17222343
Crit Rev Clin Lab Sci. 2004;41(4):339-90
pubmed: 15487592
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
pubmed: 20383002
Nature. 2010 Dec 9;468(7325):779-83
pubmed: 21085117
Pharmacol Ther. 2016 Feb;158:24-40
pubmed: 26617219
Pan Afr Med J. 2016 Apr 20;23:210
pubmed: 27347299
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):125-32
pubmed: 20124692
J Biol Chem. 2013 Jun 7;288(23):16949-16959
pubmed: 23615902
Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):293-302
pubmed: 21460447
Acta Crystallogr D Biol Crystallogr. 2013 Jul;69(Pt 7):1204-14
pubmed: 23793146
Drugs. 1991 Dec;42(6):919-44
pubmed: 1724640
J Virol. 2003 Mar;77(6):3882-7
pubmed: 12610166
J Virol. 2015 Mar;89(5):2944-55
pubmed: 25552708
J Appl Crystallogr. 2007 Aug 1;40(Pt 4):658-674
pubmed: 19461840
PLoS Negl Trop Dis. 2011 Oct;5(10):e1342
pubmed: 22022624
Mol Phylogenet Evol. 1997 Dec;8(3):301-16
pubmed: 9417890
Br J Cancer. 2000 Apr;82(8):1459-68
pubmed: 10780527
J Virol. 2015 Dec 30;90(6):2920-7
pubmed: 26719273
Can J Microbiol. 1981 Jun;27(6):568-74
pubmed: 6266626

Auteurs

Thi Hong Van Nguyen (THV)

Aix-Marseille Université and Laboratoire Architecture et Fonction des Macromolécules Biologiques (AFMB), CNRS - UMR-7257, 13288 Marseille, France.

Elsie Yekwa (E)

Aix-Marseille Université and Laboratoire Architecture et Fonction des Macromolécules Biologiques (AFMB), CNRS - UMR-7257, 13288 Marseille, France.

Barbara Selisko (B)

Aix-Marseille Université and Laboratoire Architecture et Fonction des Macromolécules Biologiques (AFMB), CNRS - UMR-7257, 13288 Marseille, France.

Bruno Canard (B)

Aix-Marseille Université and Laboratoire Architecture et Fonction des Macromolécules Biologiques (AFMB), CNRS - UMR-7257, 13288 Marseille, France.
European Virus Bioinformatics Center, Leutragraben 1, 07743 Jena, Germany.

Karine Alvarez (K)

Aix-Marseille Université and Laboratoire Architecture et Fonction des Macromolécules Biologiques (AFMB), CNRS - UMR-7257, 13288 Marseille, France.

François Ferron (F)

Aix-Marseille Université and Laboratoire Architecture et Fonction des Macromolécules Biologiques (AFMB), CNRS - UMR-7257, 13288 Marseille, France.
European Virus Bioinformatics Center, Leutragraben 1, 07743 Jena, Germany.

Classifications MeSH